
ProShares Ultra Nasdaq Biotechnology – NASDAQ:BIB
ProShares Ultra Nasdaq Biotechnology stock price today
ProShares Ultra Nasdaq Biotechnology stock price monthly change
ProShares Ultra Nasdaq Biotechnology stock price quarterly change
ProShares Ultra Nasdaq Biotechnology stock price yearly change
ProShares Ultra Nasdaq Biotechnology key metrics
Market Cap | 76.19M |
Enterprise value | N/A |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | N/A |
PEG ratio | N/A |
EPS | N/A |
Revenue | N/A |
EBITDA | N/A |
Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | N/A |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeProShares Ultra Nasdaq Biotechnology stock price history
ProShares Ultra Nasdaq Biotechnology stock forecast
ProShares Ultra Nasdaq Biotechnology financial statements
ProShares Ultra Nasdaq Biotechnology other data
Horiba: Wonderful Japanese Company At A Very Attractive Price
Week In Review: 2024 Kicks Off With 3 Deals Worth A Total Of $4B
CytoDyn: It Only Takes One Hit
Coherus: 2022 Is In Many Ways A Make Or Break Year
Can Intellia One-Up Alnylam In Transthyretin Amyloidosis?
Selecta: ImmTOR Could Change Autoimmune Disorder Treatment Landscape
SIGA Technologies: Unjustified Selloff, Loading The Boat, Best Monkeypox Play
Adicet Bio: A First Take
Incyte Corp. Should Move Higher (Technical Analysis)
-
What's the price of ProShares Ultra Nasdaq Biotechnology stock today?
One share of ProShares Ultra Nasdaq Biotechnology stock can currently be purchased for approximately $54.
-
When is ProShares Ultra Nasdaq Biotechnology's next earnings date?
Unfortunately, ProShares Ultra Nasdaq Biotechnology's (BIB) next earnings date is currently unknown.
-
Does ProShares Ultra Nasdaq Biotechnology pay dividends?
No, ProShares Ultra Nasdaq Biotechnology does not pay dividends.
-
How much money does ProShares Ultra Nasdaq Biotechnology make?
ProShares Ultra Nasdaq Biotechnology has a market capitalization of 76.19M.
-
What is ProShares Ultra Nasdaq Biotechnology's stock symbol?
ProShares Ultra Nasdaq Biotechnology is traded on the NASDAQ under the ticker symbol "BIB".
-
What is ProShares Ultra Nasdaq Biotechnology's primary industry?
Company operates in the Financial Services sector and Asset Management industry.
-
How do i buy shares of ProShares Ultra Nasdaq Biotechnology?
Shares of ProShares Ultra Nasdaq Biotechnology can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
When ProShares Ultra Nasdaq Biotechnology went public?
ProShares Ultra Nasdaq Biotechnology is publicly traded company for more then 15 years since IPO on 9 Apr 2010.
ProShares Ultra Nasdaq Biotechnology company profile:
NASDAQ
0
Asset Management
Financial Services
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
,
CIK: 0001174610
ISIN: US74347R2141
CUSIP: 74347R214